NCT01667133 2022-06-13
A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)
Takeda
Phase 1/2 Completed
Takeda
St. Petersburg State Pavlov Medical University
National Heart, Lung, and Blood Institute (NHLBI)